These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36985478)

  • 1. Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex.
    Passeri G; Northcote-Smith J; Suntharalingam K
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles.
    Eskandari A; Boodram JN; Cressey PB; Lu C; Bruno PM; Hemann MT; Suntharalingam K
    Dalton Trans; 2016 Nov; 45(44):17867-17873. PubMed ID: 27774561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reactive oxygen species-generating, cancer stem cell-potent manganese(ii) complex and its encapsulation into polymeric nanoparticles.
    Eskandari A; Suntharalingam K
    Chem Sci; 2019 Sep; 10(33):7792-7800. PubMed ID: 31588328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
    Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
    Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
    Bhattacharya S
    Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
    Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
    Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery Polymeric Poly(Lactic-Co-Glycolic Acid) (PLGA) Nanoparticles to Target Cancer Stem-Like Cells.
    Snyder CS; Repetto T; Burkhard KM; Tuteja A; Mehta G
    Methods Mol Biol; 2024; 2777():191-204. PubMed ID: 38478345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer.
    Yuan JD; ZhuGe DL; Tong MQ; Lin MT; Xu XF; Tang X; Zhao YZ; Xu HL
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):302-313. PubMed ID: 29301415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted polymeric nanoparticle for anthracycline delivery in hypoxia-induced drug resistance in metastatic breast cancer cells.
    Almoustafa HA; Alshawsh MA; Chik Z
    Anticancer Drugs; 2021 Aug; 32(7):745-754. PubMed ID: 33675612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
    Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
    Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
    Ahmad R; Kaus NHM; Hamid S
    Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
    Samkange T; D'Souza S; Obikeze K; Dube A
    J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.